UK approves use of Covid Pfizer vaccine for 12-15-year-olds

UK approves use of Covid-19 Pfizer vaccine for children aged 12-15. (PA)
The Pfizer/BioNTech Covid-19 vaccine has been approved for use for 12 to 15-year-olds, the Medicines and Healthcare products Regulatory Agency has announced.
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the use of the Pfizer Covid-19 vaccine in 12 to 15-year-olds.
The MHRA said the decision follows a “rigorous review” of safety and effectiveness in that age group.
Dr June Raine, MHRA chief executive, said: “We have carefully reviewed clinical trial data in children aged 12 to 15 years and have concluded that the Pfizer/BioNTech Covid-19 vaccine is safe and effective in this age group and that the benefits of this vaccine outweigh any risk.

Related Keywords

United Kingdom , Biontech Covid , June Raine , Nadhim Zahawi , Munir Pirmohamed , Vaccines Benefit Risk Expert Working Group , Committee On Vaccination , Commission On Human Medicines , European Medicines Agency , Paediatric Medicines Expert Advisory Group , United Kingdom Approved , Joint Committee , Human Medicines , Sir Munir Pirmohamed , Medicines Expert Advisory Group , Yellow Card , Sky New , , ஒன்றுபட்டது கிஂக்டம் , ஜூன் மழை , தடுப்பு மருந்துகள் நன்மை ஆபத்து நிபுணர் வேலை குழு , குழு ஆன் தடுப்பூசி , தரகு ஆன் மனிதன் மருந்துகள் , ஒன்றுபட்டது கிஂக்டம் அங்கீகரிக்கப்பட்டது , கூட்டு குழு , மனிதன் மருந்துகள் , மஞ்சள் அட்டை , வானம் புதியது ,